These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
319 related articles for article (PubMed ID: 30105399)
1. Sub-acute and long-term effects of ayahuasca on affect and cognitive thinking style and their association with ego dissolution. Uthaug MV; van Oorsouw K; Kuypers KPC; van Boxtel M; Broers NJ; Mason NL; Toennes SW; Riba J; Ramaekers JG Psychopharmacology (Berl); 2018 Oct; 235(10):2979-2989. PubMed ID: 30105399 [TBL] [Abstract][Full Text] [Related]
2. Ayahuasca enhances creative divergent thinking while decreasing conventional convergent thinking. Kuypers KP; Riba J; de la Fuente Revenga M; Barker S; Theunissen EL; Ramaekers JG Psychopharmacology (Berl); 2016 Sep; 233(18):3395-403. PubMed ID: 27435062 [TBL] [Abstract][Full Text] [Related]
3. Therapeutic effect of an ayahuasca analogue in clinically depressed patients: a longitudinal observational study. van Oorsouw K; Toennes SW; Ramaekers JG Psychopharmacology (Berl); 2022 Jun; 239(6):1839-1852. PubMed ID: 35072760 [TBL] [Abstract][Full Text] [Related]
4. Exploring the therapeutic potential of Ayahuasca: acute intake increases mindfulness-related capacities. Soler J; Elices M; Franquesa A; Barker S; Friedlander P; Feilding A; Pascual JC; Riba J Psychopharmacology (Berl); 2016 Mar; 233(5):823-9. PubMed ID: 26612618 [TBL] [Abstract][Full Text] [Related]
5. Enhancement of creative expression and entoptic phenomena as after-effects of repeated ayahuasca ceremonies. Frecska E; Móré CE; Vargha A; Luna LE J Psychoactive Drugs; 2012; 44(3):191-9. PubMed ID: 23061318 [TBL] [Abstract][Full Text] [Related]
6. Ayahuasca's 'afterglow': improved mindfulness and cognitive flexibility in ayahuasca drinkers. Murphy-Beiner A; Soar K Psychopharmacology (Berl); 2020 Apr; 237(4):1161-1169. PubMed ID: 31927605 [TBL] [Abstract][Full Text] [Related]
7. Health status of ayahuasca users. Barbosa PC; Mizumoto S; Bogenschutz MP; Strassman RJ Drug Test Anal; 2012; 4(7-8):601-9. PubMed ID: 22761152 [TBL] [Abstract][Full Text] [Related]
8. A single inhalation of vapor from dried toad secretion containing 5-methoxy-N,N-dimethyltryptamine (5-MeO-DMT) in a naturalistic setting is related to sustained enhancement of satisfaction with life, mindfulness-related capacities, and a decrement of psychopathological symptoms. Uthaug MV; Lancelotta R; van Oorsouw K; Kuypers KPC; Mason N; Rak J; Šuláková A; Jurok R; Maryška M; Kuchař M; Páleníček T; Riba J; Ramaekers JG Psychopharmacology (Berl); 2019 Sep; 236(9):2653-2666. PubMed ID: 30982127 [TBL] [Abstract][Full Text] [Related]
9. A placebo-controlled study of the effects of ayahuasca, set and setting on mental health of participants in ayahuasca group retreats. Uthaug MV; Mason NL; Toennes SW; Reckweg JT; de Sousa Fernandes Perna EB; Kuypers KPC; van Oorsouw K; Riba J; Ramaekers JG Psychopharmacology (Berl); 2021 Jul; 238(7):1899-1910. PubMed ID: 33694031 [TBL] [Abstract][Full Text] [Related]
10. Altered State of Consciousness and Mental Imagery as a Function of N, N-dimethyltryptamine Concentration in Ritualistic Ayahuasca Users. Ramaekers JG; Mallaroni P; Kloft L; Reckweg JT; Toennes SW; van Oorsouw K; Mason NL J Cogn Neurosci; 2023 Sep; 35(9):1382-1393. PubMed ID: 37159257 [TBL] [Abstract][Full Text] [Related]
11. Prospective examination of the therapeutic role of psychological flexibility and cognitive reappraisal in the ceremonial use of ayahuasca. Agin-Liebes G; Zeifman R; Luoma JB; Garland EL; Campbell WK; Weiss B J Psychopharmacol; 2022 Mar; 36(3):295-308. PubMed ID: 35253514 [TBL] [Abstract][Full Text] [Related]
12. Ayahuasca may help to improve self-compassion and self-criticism capacities. Domínguez-Clavé E; Soler J; Elices M; Franquesa A; Álvarez E; Pascual JC Hum Psychopharmacol; 2022 Jan; 37(1):e2807. PubMed ID: 34411343 [TBL] [Abstract][Full Text] [Related]
13. Modulatory effects of ayahuasca on personality structure in a traditional framework. Netzband N; Ruffell S; Linton S; Tsang WF; Wolff T Psychopharmacology (Berl); 2020 Oct; 237(10):3161-3171. PubMed ID: 32700023 [TBL] [Abstract][Full Text] [Related]
14. Acute effects of ayahuasca on neuropsychological performance: differences in executive function between experienced and occasional users. Bouso JC; Fábregas JM; Antonijoan RM; Rodríguez-Fornells A; Riba J Psychopharmacology (Berl); 2013 Dec; 230(3):415-24. PubMed ID: 23793226 [TBL] [Abstract][Full Text] [Related]
15. Persisting Effects of Ayahuasca on Empathy, Creative Thinking, Decentering, Personality, and Well-Being. Kiraga MK; Mason NL; Uthaug MV; van Oorsouw KIM; Toennes SW; Ramaekers JG; Kuypers KPC Front Pharmacol; 2021; 12():721537. PubMed ID: 34658861 [No Abstract] [Full Text] [Related]
16. Acute Psychological Adverse Reactions in First-Time Ritual Ayahuasca Users: A Prospective Case Series. Gómez-Sousa M; Jiménez-Garrido DF; Ona G; Dos Santos RG; Hallak JEC; Alcázar-Córcoles MÁ; Bouso JC J Clin Psychopharmacol; 2021 Mar-Apr 01; 41(2):163-171. PubMed ID: 33606432 [TBL] [Abstract][Full Text] [Related]
17. Ayahuasca: Psychological and Physiologic Effects, Pharmacology and Potential Uses in Addiction and Mental Illness. Hamill J; Hallak J; Dursun SM; Baker G Curr Neuropharmacol; 2019; 17(2):108-128. PubMed ID: 29366418 [TBL] [Abstract][Full Text] [Related]
18. Changes in spirituality among ayahuasca ceremony novice participants. Trichter S; Klimo J; Krippner S J Psychoactive Drugs; 2009 Jun; 41(2):121-34. PubMed ID: 19705674 [TBL] [Abstract][Full Text] [Related]
19. [Ayahuasca in the Netherlands: what the doctor should know about its side effects]. van den Berg A; van Eeghen EE; Kooter AJ; Tuinman TH; Tuinman PR Ned Tijdschr Geneeskd; 2020 Aug; 164():. PubMed ID: 32940978 [TBL] [Abstract][Full Text] [Related]
20. Assessing the Psychedelic "After-Glow" in Ayahuasca Users: Post-Acute Neurometabolic and Functional Connectivity Changes Are Associated with Enhanced Mindfulness Capacities. Sampedro F; de la Fuente Revenga M; Valle M; Roberto N; Domínguez-Clavé E; Elices M; Luna LE; Crippa JAS; Hallak JEC; de Araujo DB; Friedlander P; Barker SA; Álvarez E; Soler J; Pascual JC; Feilding A; Riba J Int J Neuropsychopharmacol; 2017 Sep; 20(9):698-711. PubMed ID: 28525587 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]